Stage
Incubator/Accelerator | AliveAbout Sequenom Center for Molecular Medicine
Sequenom Center for Molecular Medicine (SCMM) is an molecular pathology laboratory created specifically to support cutting-edge diagnostics, translational research and clinical trials. SCMM is primarily focused on the areas of technology development, women's health and oncology. Based in Grand Rapids, Michigan, SCMM collaborates with Spectrum Health, one of Michigan's largest not-for-profit health systems which annually aims to serve hundreds of thousands of patients, and the Van Andel Research Institute, which aims to offer translational research and bioinformatics expertise with the latest in genomics and proteomics technology.
Latest Sequenom Center for Molecular Medicine News
Mar 10, 2020
Prenatal Diagnostics Market report provides in-depth review of the Growth Drivers, Potential Challenges, Unique Trends, and Opportunities for market participants equip readers to fully comprehend the overall landscape of the Prenatal Diagnostics industry. Major top key manufactures included in the report along with Market Share, Stock Determinations and Figures, Contact Info, Sales, Capacity, Production, Price, Cost, Revenue and Business Profiles are ( Hologic, Sequenom, PerkinElmer, Ravgen, Sequenom Center for Molecular Medicine, Abbott Molecular, Angle, TrovaGene ). The primary objective of the Prenatal Diagnostics market report is to offer key insights on Competition Positioning, Current Trends, Market Potential, Growth Rates, and Other Relevant Statistics. Get Free Sample PDF (including full TOC, Tables and Figures) of Prenatal Diagnostics [email protected] https://www.researchmoz.us/enquiry.php?type=S&repid=1856828 Prenatal Diagnostics Market Competition by Manufacturers (2019-2025) Prenatal Diagnostics Market by Capacity, Production and Share by Manufacturers, Revenue and Share by Manufacturers, Prenatal Diagnostics Market Share of Top 3 and Top 5 Manufacturers, Manufacturers Manufacturing Base Distribution, Sales Area, Product Type, Market Competitive Situation and Trends, Market Concentration Rate Scope of Prenatal Diagnostics Market: Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down’s syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening. On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, Prenatal Diagnostics market share and growth rate of Prenatal Diagnostics for each application, including- Fetus Newborns On the basis of product, this report displays the sales volume, revenue (Million USD), product price, Prenatal Diagnostics market share and growth rate of each type, primarily split into- Harmony PrenaTest Verifi VisibiliT Key Questions Answered in the Prenatal Diagnostics Market Report:- Analysts of the report focused on answering some key questions about Prenatal Diagnostics market. This is to help readers gain clear knowledge about growth in the Prenatal Diagnostics market, and what are the ongoing changes taking place that will diversify the market in the coming years. What are the most recent advanced technologies adopted by Prenatal Diagnostics? How are the recent trends affecting growth in the global Prenatal Diagnostics market? What are the key strategies used by players and service providers that are expected to impact the growth of the Prenatal Diagnostics market? What are the resources available in respective regions that attract leading players in the Prenatal Diagnostics market? What was the historical value and what will be the forecast value of the Prenatal Diagnostics market? Contact:
Sequenom Center for Molecular Medicine Frequently Asked Questions (FAQ)
Where is Sequenom Center for Molecular Medicine's headquarters?
Sequenom Center for Molecular Medicine's headquarters is located at Grand Rapids.
What is Sequenom Center for Molecular Medicine's latest funding round?
Sequenom Center for Molecular Medicine's latest funding round is Incubator/Accelerator.
Who are the investors of Sequenom Center for Molecular Medicine?
Investors of Sequenom Center for Molecular Medicine include West Michigan Science & Technology Initiative New Venture Center.
Who are Sequenom Center for Molecular Medicine's competitors?
Competitors of Sequenom Center for Molecular Medicine include Oncodesign, eStudySite, Altarum Institute, Aurora Diagnostics, Cleveland HeartLab and 16 more.
Compare Sequenom Center for Molecular Medicine to Competitors

Velos provides software solutions for clinical research management. It offers a software platform with an automated research review and biospecimen management solution for trial administration, financial management, patient tracking, reporting, and many other purposes. The company was founded in 1996 and is based in Fremont, California.
NCI Cancer Hospital is a private oncology centre in Malaysia that combines treatment and clinical research. NCI aims to provide a range of services from diagnosis, laboratory analysis, surgery, chemotherapy and radiotherapy. It operates to GCP and has conducted clinical trials for a number of pharmaceutical companies including Roche, BMS and AstraZeneca.
Correlogic Systems, Inc. has developed patented technology and processes with a wide variety of applications for biomarker discovery, disease detection, and new drug discovery. The technology's first application has been in the field of proteomics – the study of human proteins. OvaCheck, a blood test for the early detection of ovarian cancer, is Correlogic's first diagnostic test using its patented "Hidden Patterns" approach. The test is undergoing the final stages of its extensive validation process. Correlogic has entered into marketing agreements with Quest Diagnostics, Inc., and Laboratory Corporation of America for North America. Mitsui & Co., Ltd. and Quest Diagnostics are equity investors in Correlogic.

Fred Hutchinson Cancer Research Center operates as a nonprofit organization. IT conducts research to generate new medical discoveries for preventing diseases and cancers. The company was founded in 1975 and is based in Seattle, Washington.
Oxensis provides optical sensors for pressure, vibration, temperature, and multiple parameters devices. It offers optical instrumentation for precision controls. It specializes in optical pressure sensor systems for power generation and sensor products for gas turbine applications. It was founded in 2003 and is based in Oxfordshire, United Kingdom.
Essential Group is a specialty clinical research and patient recruitment service organization.